Current state of immunotherapy for glioblastoma

Current state of immunotherapy for glioblastomaCurrent state of immunotherapy for glioblastoma, Published online: 11 April 2018; doi:10.1038/s41571-018-0003-5Glioblastoma is a disease associated with a dismal patient prognosis, necessitating the development of novel therapies. Substantial research effort is being devoted to the development of immunotherapies for glioblastoma. Herein, the rationale and promise for this approach are discussed, together with the challenges and how they might be overcome.
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Source Type: research